Overview

Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial assessing the time to relapse of anxiety symptoms among patients with generalized anxiety disorder who have responded to duloxetine therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride